<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN" 
"http://www.w3.org/TR/html4/strict.dtd">
<html>
<head>
<title>Agonists &amp; Signaling Agents for Tyrosine Hydroxylase</title>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<link href="/style/std.css" type="text/css" rel="stylesheet">
</head>
<body>

<table>
<caption>In situ</caption>
<tr> 
 <th>Agent 
 <th>Cell/Tissue 
 <th>Dose 
 <th>Time 
 <th>Results 
 <th>Authors
<tr> 
 <td rowspan="4"> cAMP 
 <td> rat striata 
 <td> 0.5 mM 
 <td> 
 <td> no effect on DOPA syn. 
 <td> Anagnoste et al (74)
<tr> 
 <td> PC12 cell 
 <td> 
 <td> 
 <td> TH mRNA enhanced 
 <td> Lewis et al (83)
<tr> <td rowspan="2"> bov chromaffin 
 <td> 20&nbsp;&micro;M 
 <td> 
 <td> cells made <q>leaky</q> by high voltage 
 <td> Niggli et al (84)
<tr> 
 <td> course<br>100&nbsp;&micro;M) 
 <td> 
 <td> (see also Ca<sup>2+</sup> in situ) digitonin-permeabilized cells used.    
  TH activation shown.  Also in combo with Ca<sup>2+</sup>.
 <td> Yanagihara et al (87)
<tr> 
 <td rowspan="9"> 8-Br-cAMP 
 <td rowspan="4"> bov chromaffin 
 <td rowspan="3"> 1 mM 
 <td> 
 <td> DOPA syn enhanced 
 <td> Meligeni et al (82)
<tr> 
 <td> 
 <td> TH phosphorylation, tryptic peptides C &amp; E 
 <td> Haycock et al (82a)
<tr> 
 <td> 
 <td> 2D peptide maps: two phosphopeptides (one spot increased by 8-Br-cAMP)
 <td> McTigue et al (85)
<tr> 
 <td> 2 mM 
 <td> 10 min 
 <td> see ACh section <td> Haycock (93)
<tr> 
 <td rowspan="3"> rat SCG 
 <td rowspan="2"> 1 mM 
 <td> 
 <td> see DMPP; Ca-independent TH activation 
 <td> Horwitz &amp; Perlman (84a)
<tr> 
 <td> 
 <td> no effect on phospholipid metabolism; only DOPA syn increase 
 <td> Horwitz et al (84b)
<tr> 
 <td> course 
 <td> 
 <td> DOPA synthesis (8-Br-adenosine, 8-Br-AMP, 8-Br-cGMP no effect);  
  effect is same if preganglionic elements decentralized 
 <td> Ip et al (85a)
<tr> 
 <td> PC12 cells 
 <td> 1 mM 
 <td> 30 min 
 <td> TH phoshphorylation enhanced 
 <td> Lee et al (85)
<tr> 
 <td> 
 <td> 1 mM 
 <td> 5 min 
 <td> see KCl section 
 <td> Haycock (90)
<tr> 
 <td rowspan="9"> forskolin 
 <td rowspan="2"> rat striata 
 <td rowspan="2"> 0.1 mM 
 <td> 
 <td> see Bt<sub>2</sub>cAMP for result 
 <td> El Mestikawy et al (83)
<tr> 
 <td> 
 <td> TH activation (??) 
 <td> El Mestikawy et al (85)
<tr> 
 <td> rat SCG 
 <td> course <br>  10&nbsp;&micro;M 
 <td> 
 <td> DOPA syn increased; PDE inhibitor potentiates 
 <td> Ip et al (85a)
<tr> 
 <td  rowspan="4"> bov chromaffin 
 <td  rowspan="3"> 10&nbsp;&micro;M 
 <td> 
 <td> same results as for dB-cAMP 
 <td> Pocotte et al (86)
<tr> 
 <td> 
 <td> used to see if cAMP level is raised when it is not in VIP; it is 
 <td> Houchi et al (87)
<tr> 
 <td> course 
 <td> see ACh results; HPLC tryptic phosphopeptide pattern distinguished 
 <td> Waymire et al (88)
<tr> 
 <td> 10&nbsp;&micro;M 
 <td> 30 min 
 <td> see ACh section 
 <td> Haycock (93)
<tr> 
 <td rowspan="2"> PC12 cells 
 <td> course <br>  0.1&nbsp;&micro;M 
 <td> 
 <td> (see PMA in situ) TH activation and phosphorylation;    
   Ca-independent; TFP does not inhibit; cAMP levels determined 
 <td> Tachikawa et al (87)
<tr> 
 <td> 10&nbsp;&micro;M 
 <td> 10 min 
 <td> see KCl section 
 <td> Haycock (90)
<tr> 
 <td rowspan="12"> Bt<sub>2</sub>cAMP 
 <td rowspan="3"> rat striata slices 
 <td> course 
 <td> 
 <td> 
 <td> Anagnoste et al (74)
<tr> 
 <td> 1 mM 
 <td> 
 <td> 
 <td> Simon &amp; Roth (79)
<tr> 
 <td> 2 mM
 <td>
 <td> TH activation shown to be Ca-independent, Km change for cofactor,   
  broad pH optimum; coincubation also done with forskolin;   
  K depolarization works via separate mechanism
 <td> El Mestikawy et al (83)
<tr>
 <td> rat cortex
 <td>
 <td>
 <td> CA synthesis
 <td> Taneda (74)
<tr>
 <td rowspan="6"> PC12 cells
 <td> 1 mM
 <td> 10 min
 <td> TH activation (Ca-independent); no effect on intracellular tyrosine
 <td> Chalfie &amp; Perlman (79)
<tr>
 <td> course<br> 1 mM
 <td>
 <td> Phosphorylation pattern of proteins indistinguishable from  
  NGF-treated
 <td> Halegoua &amp; Patrick (80)
<tr>
 <td>  1 mM
 <td>
 <td> 2D-PAGE: 3 isoforms, all 3 show same 2D peptide maps;  
  immunopptd TH  tryptic + 2D map:  T1-T4; for dB-cAMP:  
   T1&gt;T3 (T2, T4 no change); TH  activation also shown
 <td>  McTigue et al (85)
<tr>
 <td> 1 mM
 <td> 30 min
 <td> TH phosphoryaltion enhanced
 <td>  Lee et al (85)
<tr>
 <td>  2 mM
 <td>  course  10 min
 <td>  TH phosphorylation and  activation; HPLC of tryptic peptides: 
   only 32 min peptide (same for PK-A in  vitro)
 <td>  Tachikawa et al (86)
<tr>
 <td>  1 mM
 <td>  5 min
 <td>  see KCl section
 <td>  Haycock (90)
<tr>
 <td rowspan="2">  bov chromaffin
 <td rowspan="2">  1 mM
 <td>
 <td>
 <td>  Meligeni et al (82)
<tr>
 <td>
 <td>  TH phosphorylation and  activation, but no CA secretion
 <td>  Pocotte et al (86)
<tr>
 <td>  Na nitroprusside
 <td>   PC12 cells
 <td>  course, 100&nbsp;&micro;M
 <td>
 <td>  cGMP-mediated TH activation (methacholine has no effect)
 <td>  Roskoski &amp; Roskoski (87)
<tr>
 <td rowspan="4">  cholera toxin
 <td rowspan="4">  PC12 cells
 <td>  course  (1&nbsp;&micro;g/ml)
 <td>  course 10 min
 <td>  TH activation; cAMP level checked Vmax changed, but not Km values CA 
 synthesis checked; no effect on intracellular tyrosine
 <td>  Chalfie &amp; Perlman (79)
<tr>
 <td>
 <td>
 <td>  DOPA syn rate; Tyr content again checked; does Tyr control TH?
 <td>  Vaccaro et al (80)
<tr>
 <td>  course 1&nbsp;&micro;g/ml
 <td>
 <td>  cAMP elevated; phosphorylated protein pattern indisting. from dB-cAMP or 
 NGF-treated
 <td>  Halegoua &amp; Patrick (80)
<tr>
 <td>  1&nbsp;&micro;g/ml
 <td>
 <td>  see Bt<sub>2</sub>cAMP
 <td>  McTigue et al (85)
<tr>
 <td>  2-chloroadenosine
 <td>  PC12 cells
 <td>  50&nbsp;&micro;M
 <td>
 <td>  shown to increase cAMP
  without affecting TH phosphorylation
 <td>  Nose et al (85)
<tr> 
 <td>  secretin
 <td>  rat SCG
 <td>  course 0.1&nbsp;&micro;M
 <td>  30 min
 <td>  DOPA syn increased
 <td>  Ip et al (82a)
<tr>
 <td>
 <td>
 <td> 
 <td>
 <td>
  TH activation shown also
  for another secretin peptide (PHI); other peptides of secretin family tried
  and no effect; cAMP levels measured; effects are Ca-independent
 <td> Ip et al (85a)<br>
  Ip et al (85b)
<tr>
 <td>
 <td> bov chromffin
 <td> 10&nbsp;&micro;M
 <td> 
<td>  No effect on CA synthesis  (Cf. VIP)
 <td> Houchi et al (87)
<tr>
 <td>
 <td> symp nerve endings
 <td>
 <td> 
 <td> both VIP and secretin  increase TH activity (??)


 <td>
  Schwarzschild &amp; Zigmond
  (89)
<tr>
 <td>  PC12 cells
 <td>
 <td>
 <td>  see KCl section
 <td>  Haycock (90)
<tr>
 <td>  VIP
 <td>  rat SCG
 <td> course 10&nbsp;&micro;M
 <td> 30 min
 <td> DOPA syn increased
 <td> Ip et al (82a)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td> dose course for PHI compared to old VIP and secretin dose course; cAMP 
 levels measured; effect is Ca-independent
 <td>  Ip et al (85a)
   <br>Ip et al (85b)
<tr>
 <td>
 <td>   normal and neoplastic rat chromaffin
 <td>
 <td>
 <td>  TH activity changes (??)
 <td>  Tischler et al (85)
<tr>
 <td>
 <td>  freshly isolated bov chromaffin
 <td>  course (1.5&nbsp;&micro;M)
 <td>
 <td>  CA synthesis but no release/secretion; (secretin and substance P w/o 
 effect); Ca-independent (unlike carbachol, qv); VIP does not affect cAMP level; 
 authors show VIP works through PK-C
 <td>  Houchi et al (87)
<tr>
 <td>
 <td> chromaffin
 <td>
 <td>
 <td>  CA biosynthesis and TH activation;  mediated by PK-A phosphorylation (??)
 <td>  Waymire et al (91)
<tr>
 <td>
 <td>
 <td>  200 nM
 <td>  5 min
 <td>  see ACh section
 <td>  Haycock (93)
<tr>
 <td>
 <td>  symp nerve endings
 <td>
 <td>
 <td>  see secretin section
 <td>  Schwarzschild &amp; Zigmond (89)
<tr>
 <td>
 <td> PC12 cells
 <td>
 <td>
 <td>  see KCl section
 <td>  Haycock (90)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td>  TH content induced
 <td>  Wessels-Reiker et al (91)
<tr>
 <td>
 <td>
  rat forebrain
 <td>
 <td>
 <td>  see electric shock section VIP is w/o effect on this
  tissue; cAMP-messenger systems were working
 <td>  Haycock &amp; Haycock (91)
<tr>
 <td> rat adrenal
 <td>
 <td>
 <td>  see electric shock section
 <td>  Haycock &amp; Wakade (92)
<tr> <td> angiotensin II
 <td>  rat SCG
 <td>
 <td>
 <td>
 <td>  Ip et al (82a)
<tr>
 <td>  chromaffin
 <td>  1&nbsp;&micro;M
 <td>
 <td>  Ser-31 phosphorylation enhanced; same with Endothelin III.
 <td>  Haycock (93)
<tr> 
 <td>  bombesin
 <td>  rat SCG
 <td>
 <td>
 <td>
 <td>  Ip et al (82a)
<tr> 
 <td> bradykinin
 <td>  rat SCG
 <td>
 <td>
 <td>
 <td>  Ip et al (82a)
<tr>
 <td>
 <td>  chromaffin
 <td>  1&nbsp;&micro;M
 <td>
 <td>  Ser-31 phosphorylation enhanced
 <td>  Haycock (93)
<tr>
 <td> PC12
 <td>
 <td>
 <td>  TH phosphorylation &amp; activation; mediation apparently by 
  inositolphosphate increase; Ca levels increased too; uptake not by
  V-dependent Ca channel, La<sup>3+</sup> inhibits; PMA+bradykinin activation
  additive; probably acts throught CaM K and PK-C
 <td>  Houchi et al (90)
<tr> <td>  cholecystokinin octapeptide
 <td>  rat SCG
 <td>
 <td>
 <td>
 <td>  Ip et al (82a)
<tr> <td>  glucagon
 <td>  rat SCG
 <td>
 <td>
 <td>
 <td>  Ip et al (82a)
<tr> <td> insulin
 <td> rat SCG
 <td>
 <td>
 <td>
 <td> Ip et al (82a)
<tr>
 <td rowspan="2"> neurotensin
 <td> rat SCG
 <td>
 <td>
 <td>
 <td> Ip et al (82a)
<tr>
 <td> PC12 cells
 <td>
 <td>
 <td> see KCl section
 <td> Haycock (90)
<tr>
 <td> somatostatin
 <td> rat SCG
 <td>
 <td>
 <td>
 <td> Ip et al (82a)
<tr>
 <td> PC12 cells
 <td>
 <td>
 <td> see KCl section
 <td> Haycock (90)
<tr>
 <td> substance P
 <td> rat SCG
 <td>
 <td>
 <td>
 <td> Ip et al (82a)
<tr>
 <td>
 <td> bov chromaffin
 <td> 10&nbsp;&micro;M
 <td>
 <td> No effect on CA synthesis
 <td> Houchi et al (87)
<tr>
 <td> PC12 cells
 <td>
 <td>
 <td> see KCl section
 <td> Haycock (90)
<tr>
 <td> histamine
 <td> chromaffin
 <td> 1&nbsp;&micro;M
 <td>
 <td> Ser-19 initially increased, but Ser-31 phosphorylation later
 <td> Haycock (93)
<tr>
 <td> physiologcal depolarization
 <td> rat SCG
 <td>
 <td>
 <td> TH phosphorylation increases mediated by cAMP- and Ca-dependent 
    protein kinases (??)
 <td> Cahill &amp; Perlman (87)
<tr>
 <td> cold stress
 <td> rat adrenal gland
 <td>
 <td>
 <td> TH mRNA elevation
 <td> Tank et al (85)
<tr>
 <td> decapitation
 <td> rat adrenal
 <td>
 <td>
 <td> effect on cAMP (??)
 <td> Masserano &amp; Weiner (79)
<tr>
 <td>
 <td>
 <td>
 <td> PK-A shown not to be involved in TH activation after decapitation
 <td> Tank et al (84)
<tr>
 <td> electric shock
 <td> dopaminergic neurons
 <td>
 <td>
 <td> TH activation (??)
 <td> Murrin et al (76)
<tr>
 <td>
 <td> sym ganglia
 <td>
 <td>
 <td> TH activation (??)
 <td> Zigmond &amp; Ben-Ari (77)
<tr>
 <td>
 <td> neurons
 <td>
 <td>
 <td> TH activation
 <td> Weiner et al (78)
<tr>
 <td>
 <td> rat SCG
 <td>
 <td>
 <td> TH phosphorylation (??)
 <td> Cahill &amp; Perlman (84)
<tr>
 <td>
 <td> rat med forebrain bundle
 <td>
 <td>
 <td> TH phosphorylation monitored by TLE/C analysis of tryptic peptide,
   increases in Ser-19, -31, -40.  K-depolarized, Ser-31 increased
  relative to -19; adenosine receptor stimulation did not effect electrical
  results; VIP has no effect on this tissue
 <td> Haycock &amp; Haycock (91)
<tr>
 <td> rat adrenals
 <td>
 <td>
 <td> splanchnic nerves field-stimulated at different freq.
  Low freq for 5 min show Ser-19, -31, -40 phosphorylation.
  High freq, 30 s only Ser-19 and -40.
  Low freq shows greater activation (maybe  higher P in Ser-40 and -31);
  nicotine enhances mainly Ser-19, but 50% in Ser-31 and -40
  (no effect on TH activity).
  Muscarine enhances Ser-19 and -31, a little in -40 (no effect on TH
  activity).  VIP enhances only Ser-40 significantly (activates TH)
 <td> Haycock &amp; Wakade (92)
<tr>
 <td> ACh
 <td> bov chromaffin
 <td>
 <td>
 <td> TH phosphoryaltion &amp; activation, tryptic peptides
 <td> Haycock et al (82a &amp; b)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td> Most of the phosphorylated TH found in soluble cell portion
 <td> Haycock et al (85)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td> TH phosphorylation increased
 <td> Pocotte et al (86)
<tr>
 <td>
 <td>
 <td>
 <td> course
 <td> CA secretion stimulated; PAGE-purified TH trypsinized; HPLC:
   7 peptides in controls; ACh stimulates pep. 3-7, with 3,5,6
   in first 15 sec;  pep 4, 7 increase slowly, grad’ly; ATP pool does
   not change; Ca-dependent; forskolin shows different pattern:
   only pep 6 phosphorylation enhanced
 <td> Waymire et al (88)
<tr>
 <td>
 <td>
 <td> 100&nbsp;&micro;M
 <td> 1, 2 min
 <td> Phosphorylation of several proteins followed incl. TH.
      TH phosphorylated by variety of agents:  nicotine, A23187,
      veratridine, K; Ca-dependence shown for nicotinic;
      PDBu, other phorbol esters, and DAGs also shown to enhance phos.
 <td> Haycock et al (88)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td> TH site phosphorylation watched:  with ACh, increases in
  Ser-19, -40 initially, then -31 later (CaMMPK II action?).
  Rate of site phosphorylation temperature-dependent.
  Nicotine (5 min) like ACh: more in Ser-31 than in -19 and -40;
  muscarine shows Ser-31 with drop in Ser-19 over long term;
  KCl, veratridine, BaCl2 show same effect as nicotine;
  VIP over long term enhances Ser-40 and -31;
  forskolin, 8BrcAMP show only Ser-40;
  phorbol esters both Ser-31 and -40 long term;
  okadaic acid (all but Ser-8);
  NGF did not significantly affect any.
 <td> Haycock (93)
<tr>
 <td>
 <td> PC12 cells
 <td> 100&nbsp;&micro;M
 <td>
 <td> TH phosphorylation enhanced; nitrendipine blocks;
      K-depolarized TH and 2D-PAGE show 3 isoforms.
 <td> Nose et al (85)
<tr>
 <td> carbachol (carbamylcholine)
 <td> PC12 cells
 <td> 100&nbsp;&micro;M
 <td> course
 <td> change in TH phosphorylation over time assessed;
      Ca-dependence shown; nitrendipine in increasing doses also inhibits;
      similar effects with A23187
 <td> Nose et al (85)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td> see KCl section
 <td> Griffith &amp; Schulman (88)
<tr>
 <td>
 <td> bov chromaffin
 <td>   course; mixed with ACh
 <td>
 <td> TH phosphorylation enhanced just as with DMPP;
      mecamylamine inhibits carbachol more than does atropine;
      CA secretion strictly by nicotinics, not muscarinics;
      carbachol induces cAMP level increases between 2-5 min time period (same for DMPP)
 <td> Pocotte et al (86)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td> 3-fold greater CA synthesis than with VIP
 <td> Houchi et al (87)
<tr>
 <td> nicotinic
 <td> rat SCG
 <td>
 <td>
 <td>
 <td> Ip et al (82b)
<tr>
 <td> nicotine
 <td> bov chromaffin
 <td> 50&nbsp;&micro;M
 <td>  2 min
 <td> see ACh section
 <td> Haycock et al (88)
<tr>
 <td>
 <td>
 <td> 10&nbsp;&micro;M
 <td>
 <td> see ACh section
 <td> Haycock (93)
<tr>
 <td>
 <td> PC12 cells
 <td> 50&nbsp;&micro;M
 <td> courses
 <td> see KCl section
 <td> Haycock (90)
<tr>
 <td> rat adrenal
 <td>
 <td>
 <td> see electric shock section
 <td> Haycock &amp; Wakade (92)
<tr>
 <td>  high KCl
 <td>  rat striata slices
 <td>  40 mM
 <td>
 <td> 
 <td> Anagnoste et al (74)
<tr>
 <td>
 <td>
 <td>  ?
 <td>
 <td>  ethanol has effect (?) on activ.
 <td>  Bustos et al (76)
<tr>
 <td>
 <td>
 <td>  60 mM
 <td>  course
 <td>  TH activation; additive to dB-cAMP
 <td>  Simon &amp; Roth (79)
<tr>
 <td>
 <td>
 <td>
  60 mM + 4&nbsp;&micro;M Ca
 <td>
 <td>  TH activation, shown to be Ca-dependent; Vmax change only
 <td>  El Mestikawy (83)
<tr>
 <td>
 <td>
 <td><td>
 <td>  TH activation study (??)
 <td>  El Mestikawy et al (85)
<tr>
 <td>
 <td>  PC 12
 <td> 56 mM
 <td>
 <td>  TH activated; Vmax changed but not Km for cofactor or
  tyrosine; alters intracellular tyrosine (raises it)
 <td>  Chalfie et al (79)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td>  DOPA syn rate; Tyr content checked again: case made for Tyr control of TH activity
 <td>  Vaccaro et al (80)
<tr>
 <td>
 <td>
 <td>  course 56 mM
 <td>  course
 <td>  TH activation and phosphorylation
 <td>  Yanagihara et al (84)
<tr>
 <td>
 <td>
 <td>  40 mM
 <td>
 <td>  Ca-depenedent; tryptic peptids on 2D-map  T2&gt;T3 increased, 
   no change in T1, T4;  TH activation also shown
 <td>  McTigue et al (85)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td>  2D-PAGE of TH shows 3
  isoform (non-, mono-, diphosphorylated); TH activation; effect nicotinic
  since tubocurarine blocks but methacholine does not.
 <td>  Nose et al (85)
<tr>
 <td>
 <td>
 <td>  course 40-60 mM
 <td>  course 30 min
 <td>  (see also NGF treatment)
  TH phosphorylation
  enhanced; biphasic incorporation with K; TH activation studied over time too;
  Ca-dependent; TFP abolishes effect; W5 and W7 used (W7 reduces a great deal)
 <td>  Lee et al (85)
<tr>
 <td>
 <td>
 <td> 56 mM
 <td>
 <td>  TH phosphorylated at more than one site
 <td>  Yanagihara et al (86)
<tr>
 <td>
 <td>
 <td> 
 <td>
 <td>  Tryptic peptides on HPLC:  increases P in 18, 22, 32, not 24 min peptide
 <td>  Tachikawa et al (86)
<tr>
 <td>
 <td>
 <td>
 <td>  5 min
 <td>  100&nbsp;&micro;M carbachol, 10&nbsp;&micro;M A23187, 1&nbsp;&micro;M 
 TPA, 200&nbsp;&micro;M OAG:  TH phosphorylation studied; all P incorp increases 
 with higher calcium; nitrendipine and calmidazolium block; 2D PAGE shows 
 differential phosphorylation with TPA and K+; long-term TPA treatments do not 
 affect PK-A or CaM kinase activities;  Ca levels do not affect PK-A activity or 
 cAMP levels
 <td>  Griffith &amp; Schulman  (88)
<tr>
 <td>
 <td>
 <td>  56 mM
 <td>
 <td>  TH activation &amp; phosphorylation; also NGF-treated. Tryptic peptides 
 on HPLC;  H25 shows greater P incorp for NGF and KCl than others; in vitro 
 kinases also checked
 <td>  Mitchell et al (89)
<tr>
 <td>
 <td>
 <td>  40 mM
 <td>  courses
 <td>  TH site phosphorylation studied.  Other agents: veratridine, nicotine; 
 30-60 s treatments enhance HPLC peaks 1 and 2 (Ca-dependent), longer (5 min) 
 enhance peak 5; A23187 for long period enhances peaks 1,2, and 3.  Forskolin 
 and cAMP analogues singly enhance peak 5.  Secretin and VIP (but no sub P, 
 neurotens, somat) increased peak 5. Phorbol esters show increase in peak 3, 
 small increase in peak 5; NGF increase peak 3; EGF has no effect; okadaic acid 
 increase P in all peptides
 <td>  Haycock (90)
<tr>
 <td>
 <td>  bov. chromaffin
 <td>
 <td>
 <td>  TH phosphorylation &amp; activation; 2D-PAGE shows 3 isophosphoforms same 
 as for DMPP
 <td>  Pocotte et al (86)
<tr>
 <td>
 <td>
 <td>  55 mM
 <td>
 <td>  see ACh section; results on HPLC phosphopeptides same as with ACh 
 stimulation
 <td>  Waymire et al (88)
<tr>
 <td>
 <td>
 <td>  40 mM
 <td>  2 min
 <td>  see ACh section
 <td>  Haycock et al (88)
<tr>
 <td> med forebrain bundle
 <td>
 <td>
 <td>  see electric shock section
 <td>  Haycock &amp; Haycock (91)
<tr>
 <td>  Ca<sup>2+</sup>
 <td>  bov. chromaffin
 <td>  10 nM &amp; 10&nbsp;&micro;M
 <td>
 <td>  see cAMP above
 <td>  Niggli et al (84)
<tr>
 <td>
 <td>  course  1&nbsp;&micro;M
 <td>
 <td>  cells permeabilized by 30 &nbsp;&micro;M digitonin;  TH activation shown, 
 with ATP essential for effect
 <td>  Yanagihara et al (87)
<tr>
 <td> veratridine
 <td>  bov chromaffin
 <td>  150&nbsp;&micro;M
 <td>  2 min
 <td>  see ACh section
 <td>  Haycock et al. (88)
<tr>
 <td> PC12 cells
 <td>  100&nbsp;&micro;M
 <td>  course
 <td>  see KCl section
 <td>  Haycock (90)
<tr>
 <td>  DMPP
 <td> rat SCG
 <td>  0.1 mM
 <td>
 <td>  increased DOPA synthesis; Ca-dependent to a degree; rapid responser, 
 shorter acting than muscarinic activation; Vmax and cofactor Km change 
 documented
 <td>  Horwitz &amp; Perlman (84)
<tr>
 <td>
 <td>
 <td>  0.1 mM
 <td>
 <td>  TH activation, but no effect on cAMP level.  Shown to be Ca-dependent
 <td>  Ip et al (85a)
<tr>
 <td> bov chromaffin
 <td>  10&nbsp;&micro;M
 <td>  course; 5 min
 <td>  TH phosphorylation; 3 isoforms on 2D-PAGE (see also PMA); phosphorylation 
 shows as early as 30 s, remains for 5 min.; DOPA syn. measured also; Barium 
 could be used in place of calcium to enhance both phosphlytion and activation; 
 cAMP level increases after a time
 <td>  Pocotte &amp; Holz (86)
<tr>
 <td>  A23187
 <td> PC12 cell
 <td>  10&nbsp;&micro;M
 <td>
 <td>  see KCl (same effect as KCl).
 <td>  Nose et al (85)
<tr>
 <td>
 <td>
 <td>  10&nbsp;&micro;M
 <td>  course 10 min
 <td>  TH phosphoryaltion and activation enhanced; Ca-dependent; phosphorylation 
 rapid and increase not parallel with activation time course; HPLC peptide 
 analysis same as for KCl data (qv); additivity checked with KCl and with 
 dB-cAMP
 <td>  Tachikawa et al (86)
<tr>
 <td>
 <td>
 <td>  10&nbsp;&micro;M
 <td>
 <td>  see KCl
 <td>  Griffith &amp; Schulman (88)
<tr>
 <td>
 <td>  10&nbsp;&micro;M
 <td>  30 min
 <td>  see KCl section
 <td>  Haycock (90)
<tr>
 <td>  bov chromaffin`
 <td>  10&nbsp;&micro;M
 <td>  10 min
 <td>  see ACh section
 <td>  Haycock et al (88)
<tr>
 <td>  ionomycin
 <td>  PC12 cells
 <td>  1&nbsp;&micro;M
 <td>
 <td>  (see PMA also) TH activation and phosphorylation; peptides of HPLC done
 <td>  Tachikawa et al (87)
<tr>
 <td> bethanecol
 <td> rat SCG
 <td> 1 mM
 <td>
 <td> see DMPP; Ca-independent
 <td> Horwitz &amp; Perlman (84a)
<tr>
 <td>
 <td>
 <td>
 <td> less effective than muscarine in enhancing DOPA syn., PI labeling
 <td> Horwitz et al (84b)
<tr>
 <td> muscarine
 <td> rat SCG
 <td>
 <td>
 <td> see DMPP; actually most effective muscarinic
 <td> Horwitz &amp; Perlamn (84a)
<tr>
 <td>
 <td>
 <td> course 1&nbsp;&micro;M
 <td>
 <td> Phospholipids analyzed; muscarine enhances labeling of PA and PI;
  Li<sup>+</sup> inhibits somewhat; atropine blocks; does not act through cGMP
 <td> Horwitz et al (84b)
<tr>
 <td>
 <td> bov chromaffin
 <td>
 <td>
 <td> small enhancement of TH phosphorylation
 <td> Pocotte et al (86)
<tr>
 <td>
 <td>
 <td> 100&nbsp;&micro;M
 <td> 2 min
 <td> No significant TH phosphorylation shown
 <td> Haycock et al (88)
<tr>
 <td>
 <td>
 <td>
 <td> 5 min
 <td> see ACh section
 <td> Haycock (93)
<tr>
 <td> rat adrenal
 <td>
 <td>
 <td> see electric shock section
 <td> Haycock &amp; Wakade (92)
<tr>
 <td> methacholine
 <td> bov chromaffin
 <td>
 <td>
 <td> see muscarine above
 <td> Pocotte et al (86)
<tr>
 <td> muscarinic
 <td> rat SCG
 <td>
 <td>
 <td>
 <td> Ip et al (82b)
<tr>
 <td> pilocarpine
 <td>
 <td>
 <td>
 <td> see DMPP
 <td> Horwitz &amp; Perlamn (84a)
<tr>
 <td> oxotremorine
 <td>
 <td>
 <td>
 <td> see DMPP
 <td> Horwitz &amp; Perlamn (84a)
<tr>
 <td> reserpine
 <td> rat adrenal gland
 <td>
 <td>
 <td> TH mRNA increased (??)
 <td> Tank et al (85)
<tr>
 <td> PDBu
 <td> rat SCG
 <td>
 <td>
 <td> TH activation (??)
 <td> Wang et al (86)
<tr>
 <td>
 <td> bov chromaffin
 <td>
 <td>
 <td> TH phosphorylation &amp; activation; phorbol-12,13-didecanoate is w/o 
 effect; was not Ca-dependent; no changes in cAMP levels (see also PMA and DMPP)
 <td> Pocotte &amp; Holz (86)
<tr>
 <td>
 <td>
 <td> 1&nbsp;&micro;M
 <td> 10 min
 <td> see ACh section
 <td> Haycock et al (88)
<tr>
 <td>
 <td>
 <td> 50&nbsp;&micro;M
 <td> 10 min
 <td> see ACh section
 <td> Haycock (93)
<tr>
 <td>
 <td> PC12 cells
 <td> 1&nbsp;&micro;M
 <td> 15 min
 <td> see KCl section
 <td> Haycock (90)
<tr>
 <td> rat synaptosome
 <td> 1&nbsp;&micro;M
 <td> 5 min
 <td>  see also electric shock section;  increases Ser-31 phosphorylation
 <td> Haycock &amp; Haycock (91)
<tr>
 <td> PMA (TPA)
 <td> PC12 cells
 <td> 140 ng/ml
 <td>
 <td> tryptic peptide + 2D map:  T3 only enhanced;
  TH activation also shown; see Bt<sub>2</sub>cAMP
 <td> McTigue et al (85)
<tr>
 <td>
 <td>
 <td> course  70 nM
 <td> course
 <td> TH phosphorylation increased, show to be long term;
     T3 peptide again shown; CPZ and TFP could block action
 <td> Cremins et al (86)
<tr>
 <td>
 <td>
 <td> 2&nbsp;&micro;M
 <td> course 15 min
 <td> TH phosphorylation &amp; activation seen; shown to be Ca-independent; TFP 
 could be shown to inhibit; time course of phosphorylation and activation shown 
 to lag forskolin; HPLC peptide analysis: 17, 20, 23, 28 in control. Ionomycin 
 increases 17, 20, 28.  K-depolarized and A23187 identical. PMA &amp; OAG 
 enhance 20 min, forskolin the 28 min
 <td> Tachikawa et al (87)
<tr>
 <td>
 <td>
 <td> 1&nbsp;&micro;M
 <td>
 <td> see KCl section
 <td> Griffith &amp; Schulman (88)
<tr>
 <td>
 <td>
 <td> course 0.1&nbsp;&micro;M
 <td> course
 <td> long-term course followed:  PDBu-binding changes from down-regulation;
  both cytosolic and membrane localization fall;
  membrane PK-C increases initially, then total PK-C drops in long term
  (result of proteolysis); TH mRNA shown to increase initially,
  then drop in long term; leupeptin inhibits (inhibits calpain
  which degrades PK-C); PK-C changes may not effect transcripiton
  of TH mRNA, but may act post-transcriptionally
 <td> Vyas et al (90)
<tr>
 <td>
 <td> bov chromaffin
 <td> course<br>
      100 nM
 <td> 30 min
 <td> DOPA syn. increased after 5 min lag
 <td> Pocotte &amp; Holz (86)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td> found not to be additive with VIP treatment.
      H7 (PK-C inhibitor) prevents VIP- and TPA-induced increases
 <td> Houchi et al (87)
<tr>
 <td>
 <td>
 <td> 1&nbsp;&micro;M
 <td>
 <td> used to study digitonin-permeabilized cells in combination
  with Ca treatment; Note that TPA and Ca have additive response.
 <td> Yanagihara et al (87)
<tr>
 <td>
 <td>
 <td> 1&nbsp;&micro;M
 <td> 10 min
 <td> see ACh section
 <td> Haycock et al (88)
<tr>
 <td>
 <td> 2 mM
 <td> 10 min
 <td> see ACh section
 <td> Haycock (93)
<tr>
 <td> DAG
 <td>
 <td>
 <td>
 <td> OAG and OOG (OOG more potent) both shown
      to increase TH phosphorylation
 <td> Cremins et al (86)
<tr>
 <td>
 <td> PC12 cells
 <td>
  minor course<br>
  400&nbsp;&micro;g/ml
 <td>
 <td>
  OAG measured: TH phosphorylation and activity increased;  Ca-independent.
 <td> Tachikawa et al (87)
<tr>
 <td>
 <td>
 <td> 200&nbsp;&micro;M
 <td> 5 min
 <td> see KCl section; OAG used
 <td> Griffith &amp; Schulman (88)
<tr>
 <td> bov chromaffin
 <td> 10&nbsp;&micro;M
 <td> 10 min
 <td> see ACh section; OOG used and same effect on
      TH phosphoryaltion as phorbol esters
 <td> Haycock et al (88)
<tr>
 <td> adenosine
 <td> PC12 cells
 <td>
 <td>
 <td> TH activated
 <td> Erny et al (81)
<tr>
 <td> NGF
 <td> PC12 cells
 <td> 50 ng/ml
 <td>
 <td> Specific proteins followed, one is TH
 <td> Halegoua &amp; Patrick (80)
<tr>
 <td>
 <td>
 <td> course<br>
  50 ng/ml
 <td> course 30-60 min
 <td> TH activation; effect of NGF shown to be specific
     (use of anti-NGF inhibits); Vmax but no Km changes
 <td> Greene et al (84)
<tr>
 <td>
 <td>
 <td> 50 ng/ml
 <td>
 <td> tryptic peptide + 2D map:  T3&gt;T1 increased;
  TH activation also shown see Bt<sub>2</sub>cAMP
 <td> McTigue et al (85)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td> shown not to affect the activity of a Ca/CaM-dependent
     protein kinase when PC12 cells grown in NGF
 <td> Nose et al (85)
<tr>
 <td>
 <td>
 <td> course<br>
  50 ng/ml
 <td> 30 min
 <td> TH phosphorylation enhanced; slower increase than
     with K-depolarization; TH activation studied with time too;
      Ca-independent; TFP reduces effect somewhat (may be PK-C)
 <td> Lee et al (85)
<tr>
 <td>
 <td>
 <td> 50 ng/ml
 <td>
 <td> see KCl section
 <td> Mitchell et al (89)
<tr>
 <td>
 <td>
 <td> 50 ng ml
 <td> 30 min
 <td> see KCl section
 <td> Haycock (90)
<tr>
 <td>
 <td> PC12 plus PK-A deficient PC12
 <td>
 <td>
 <td> NGF enhanced T3 and T1
      (T3&gt;&gt;T1), but CPZ inhibits T3 increases.
      (So did TFP).  T1 was shown to be controlled by
       PK-A mediated phoshphorylation by careful studies
 <td> Cremins et al (86)
<tr>
 <td>
 <td> calf chromaffin
 <td> 0.8&nbsp;&micro;g/ml
 <td> course
 <td>
  low-density cultures:  TH activated after 5-10 min in
  NGF-treated;  cells on lamin show
  larger increase; AdoMet inhibitors added before NGF inhibit activation;
  cAMP-stimulated cells not affected by inhibitors
 <td> Acheson &amp; Thoenen (87)
<tr>
 <td>
 <td> rat striata synatosomes
 <td> 50 ng/ml
 <td> 5-15 min
 <td>
  (see electric shock and
  PDBu sections) no enhanceement of Ser-31 phosphroyatlion
 <td> Haycock &amp; Haycock (91)
<tr>
 <td> bov chromaffin
 <td> 200 ng/ml
 <td>
 <td> see ACh section
 <td> Haycock (93)
<tr>
 <td> EGF
 <td> PC12 cells
 <td>
 <td>
 <td> TH phosphorylation increased (additive with cAMP)
 <td> Halegoua &amp; Patrick (80)
<tr>
 <td>
 <td>
 <td> 10 ng/ml
 <td>
 <td> tryptic peptide + 2D map:  T4=T3 increased;
  TH activation also shown; see Bt<sub>2</sub>cAMP
 <td> McTigue et al (85)
<tr>
 <td>
 <td>
 <td> course
 <td> course
 <td> see KCl section; no effect on TH phosphorylation
 <td> Haycock (90)
<tr>
 <td>
 <td>
 <td>
 <td> TH gene control by EGF
 <td> Lewis &amp; Chikaraishi (87)
<tr>
 <td> IGF-I
 <td> bov chromaffin
 <td>
 <td>
 <td> TH activation
 <td> Dahmer &amp; Perlman (88)
      Dahmer &amp; Perlman (91)
<tr>
 <td> insulin
 <td> PC12 cells
 <td>
 <td>
 <td>  No effect on TH
  phosphorylation


 <td>  Halegoua &amp; Patrick (80)
<tr>
 <td>
 <td>
 <td>
 <td>  No TH activation


 <td>  McTigue et al (85)
<tr> <td>  Dexamethasone


 <td>  PC12 cells
 <td>
 <td>
 <td>  enzyme induction RNA synthesis shown
 <td>  Edgar &amp; Thoenen (78) Rohrer et al (78)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td>  TH induction by NGF permitted by glucorticoids
 <td>  Otten &amp; Towbin (80)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td>
 <td>  Lewis et al (83)
<tr>
 <td>
 <td>  PC18 cells
 <td>
 <td>
 <td>  TH synthesis regulated; checked in combination with variety of 
 cAMP-inducing agents
 <td>  Tank et al (86a)
<tr>
 <td>
 <td>  PC18 cells
 <td>
 <td>
 <td>  TH transcriptional control
 <td>  Tank et al (86b)
<tr>
 <td>
 <td>
 <td>
 <td>  Transcriptional regulation of TH gene.  One CRE in rat.
 <td>  Lewis et al (87)
<tr>
 <td>  diphenylhydantoin
 <td>  PC12 cells
 <td>
 <td>
 <td>  Ca<sup>2+</sup> blocking of K stimulation (both CA syn and TH activ 
 blocked)
 <td>  Chalfie &amp; Perlman (77)
<tr>
 <td>  cell density
 <td> PC12 cells
 <td>
 <td>
 <td>  Controls TH activation
 <td>  Lucas et al (79)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td>  TH mRNA levels controled by cell-cell contact (??)
 <td>  Saadat &amp; Thoenen (88)
<tr>
 <td>
 <td>  bov chromaffin
 <td>
 <td>
 <td>  TH induction mimicked by plasma membranes
 <td>  Saadat &amp; Thoenen (86)
<tr>
 <td>
 <td>
 <td>
 <td>  TH levels (??) influenced by cell contact
 <td>  Saadat et al (87)
<tr>
 <td> Phospholipase C
 <td>  rat SCG
 <td>  7.5 U/ml
 <td>
 <td>  DOPA synthesis enhanced; PLase-A<sub>2</sub> has little effect; 
 arachidonic acid has little effect
 <td>  Horwitz et al (84b)
<tr>
 <td> deoxycholate
 <td>  rat SCG
 <td>  1 mM
 <td>
 <td>  DOPA synthesis enhanced
 <td>  Horwitz et al (84b)
<tr>
 <td> digitonin
 <td>  rat SCG
 <td>  0.1 mM
 <td>
 <td>  DOPA syn. enhanced
 <td>  Horwitz et al (84b)
<tr> <td> &omega;-conotoxin
 <td> symp nerve endings
 <td>
 <td>
 <td> TH activation inhibited (??)
 <td> Rittenhouse &amp; Zigmonde (91)
<tr>
 <td> KN-62
 <td> PC12h cells
 <td> course <br> 10&nbsp;&micro;M
 <td>
 <td> K-depolarized-induced phosphorylation and activation of TH inhibited.
  KN-62 known inhibitor of Ca/CaM kinase;
  had no effect on PK-A stimulated pathways causing TH phoshorylation
  and activation
 <td> Ishii et al (91)
<tr>
 <td> ethanol
 <td> N1E-115 neuroblastoma
 <td>
 <td>
 <td> TH protein increases with higher EtOH doses;
   TH mRNA also increases; TH promoter on CAT reporter studied;
   additive to cAMP-stimulation by PGE1
 <td> Gayer et al (91)
</table>


<table style="margin:2em auto;">
<tr>
 <td> ATP bov adr med ext
 <td>  course for NTPs
 <td>
 <td> all NTP activate TH (NTP:  8 mM maximal)
     Cofactor K<sub>m</sub> reduced, no effect on V<sub>max</sub>
 <td> Morita et al (77)
<tr>
 <td>
 <td>
 <td>
 <td> course
 <td>
 <td> Yamauch &amp; Fuj (79b)
<tr>
 <td>
 <td> rat striata
 <td>
 <td>
 <td> Cofactor K<sub>m</sub> shown reduced
 <td> Ames et al (78)
<tr>
 <td>
 <td> rat adr med
 <td>
 <td>
 <td> Cofactor K<sub>m</sub> shown reduced
 <td> Ames et al (78)
<tr>
 <td>
 <td> rat hypothalamu
 <td>
 <td>
 <td> Cofactor K<sub>m</sub> shown reduced
 <td> Ames et al (78)
<tr>
 <td> bov striata
 <td>
 <td>
 <td> phosphorylation of TH shown
 <td> Edelman et al (78)
<tr>
 <td> ADP
 <td> bov adr med ext
 <td>
 <td>
 <td> activate less than NTP
 <td> Morita et al (77)
<tr>
 <td> AMP
 <td> bov adr med ext
 <td>
 <td>
 <td> activate less than NTP or ADP
 <td> Morita et al (77)
<tr>
 <td> adenosine
 <td> bov adr med ext
 <td>
 <td>
 <td> without effect on TH activ.
 <td> Morita et al (77)
<tr>
 <td> cAMP
 <td> rat hippocampal ext
 <td> course
 <td> course
 <td> TH activity 3-fold (EDTA inhibits (1&nbsp;&micro;M max)
 <td> Morgenroth et al (75)
<tr>
 <td>
 <td>  bovine caudate
 <td>  ?
 <td>  ?
 <td>  ?TH activation
 <td>  Lloyd &amp; Kaufman (75)
<tr>
 <td>
 <td> synaptosomes
 <td>  1 mM
 <td>
 <td>  no effect on TH activity
 <td>  Goldstein et al (75)
<tr>
 <td> bov adr med ext.
 <td>  5&nbsp;&micro;M
 <td>
 <td>  TH activation and  phosphorylation
 <td>  Yamauch &amp; Fuj (79b)
<tr>
 <td> rat brainstem
 <td>
 <td>
 <td>  activity vs pH (broad curve); additive with calcium
 <td>  Yamauch &amp; Fuj (80a)
<tr>
 <td> rat adrenal
 <td>
 <td>
 <td>  said to affect TH activation
 <td>  Yamauch &amp; Fuj (80a)
<tr>
 <td> chromaffin cell secretory vesicle
 <td>  5&nbsp;&micro;M
 <td>
 <td>  TH phosphoryaltion association of PK-A with membrane
 <td>  Treiman et al (83)
<tr>
 <td> rat strial extrcts
 <td>
 <td>
 <td>  Shows that the TH inactivation by phosphorylation is really PK-A 
 deactivation followed by TH dephosphorylation
 <td>  Vrana &amp; Roskoski (83)
<tr>
 <td> bov chromaffin extracts
 <td>  course
 <td>
 <td>  (see also the calcium section) TH phosphorylation increased; 
 calcium-independent (see calcium section); cGMP has no effect unlike Roskoski 
 &amp; Roskoski (87); PK-A cat subunit same effect as cAMP.  cAMP addition to Ca 
 did not enhance activity more than cAMP alone
 <td>  George et al. (89)
<tr> <td>  8-Br-cAMP synaptosomes
 <td>  1 mM
 <td>
 <td>
 <td>  Harris et al (74)
<tr>
 <td>  bov chromaffin
 <td>  5&nbsp;&micro;M
 <td>
 <td>  Most phosphorylation of TH occurs in a soluble TH location 
  (see also Ca, and ACh in situ); same with high Ca<sup>2+</sup>
 <td>  Haycock et al (85)
<tr>
 <td>  Bt<sub>2</sub>cAMP synaptosomes
 <td>  1 mM
 <td>
 <td>
 <td>  Harris et al (74)
<tr>
 <td>
 <td>
 <td>  .05, .5, 1 mM
 <td>
 <td>
 <td>  Goldstein et al (75)
<tr>
 <td> PtdSer  bov caud TH
 <td>
 <td>
 <td>
 <td>  Lloyd &amp; Kaufman (74)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td>
 <td>  Katz et al (76)
<tr>
 <td>  chromaffin extracts
 <td>  course
 <td>
 <td>  TH phosphorylation studied with Ca present; did not cause activation
 <td>  George et al (89)
<tr>
 <td>  Phospho-lipid
 <td>  rat striata synaptosome
 <td>  ??
 <td>
 <td>  TH activation
 <td>  Raese et al (76)
<tr>
 <td> cGMP
 <td>  rat hippocamp.
 <td>  1&nbsp;&micro;M
 <td>
 <td>  Activity inhib in control and cAMP-activated
 <td>  Morgenroth et al (75)
<tr>
 <td>
 <td>  bov adr med
 <td>  0.1 mM
 <td>
 <td>  no effect on TH phosphorylation
 <td>  Yamauchi &amp; Fuj (79b)
<tr>
 <td> chromaffin extracts
 <td>
 <td>
 <td>  no effect on TH phosphoyrlation (see cAMP section)
 <td>  George et al (89)
<tr>
 <td> AMP
 <td>  rat hippocamp.
 <td>  1,10, 100&nbsp;&micro;M
 <td>
 <td>
 <td>  Morgenroth et al (75)
<tr>
 <td> cCMP
 <td>  rat hippocamp.
 <td>  1,10, 100&nbsp;&micro;M
 <td>
 <td>
 <td>  Morgenroth et al (75)
<tr>
 <td>  cUMP
 <td>  rat hippocamp.
 <td>  1,10, 100&nbsp;&micro;M
 <td>
 <td>
 <td>  Morgenroth et al (75)
<tr>
 <td> NaCl
 <td>  bov caudate
 <td>  0.5 M
 <td>
 <td>  many univalent ions
  activate TH (LiCl, KCl, NaBr, etc.)
 <td>  Katz et al (76)
<tr>
 <td>heparin
 <td>  bov. caudate
 <td>  1 mg/ml
 <td>
 <td>  10-fold activation
 <td>  Katz et al (76)
<tr>
 <td>
 <td>  bov. adr. med.
 <td>  EC<sub>50</sub>=4&nbsp;&micro;M
 <td>
 <td>  dextran sulfate also:  TH activation
  Vmax changes (Cofactor Km changes if MES used
 <td>  Vigny &amp; Henry (81)
<tr>
 <td>  pur bov striatum
 <td>  2 mg/ml
 <td>
 <td>  TH activation (no additional activation if PK-A-treated)
 <td>  Lazar et al (82)
<tr>
 <td> MES
 <td>  purified bov. striatum
 <td>
 <td>
 <td>  seen to activate TH; changes pH optimum curve
 <td>  Lazar et al (82)
<tr> <td> polyGlu (D &amp; L)
 <td>
 <td>
 <td>
 <td>
 <td> Katz et al (76)
<tr>
 <td rowspan="6"> Ca<sup>2+</sup>
 <td rowspan="2"> bov adr med ext
 <td> 1 mM
 <td>
 <td> no added TH activation with ATP addition
 <td> Morita et al (77)
<tr>
 <td> 0.1 &amp; 2 mM
 <td>
 <td> at 2 mM, TH activation and phosporylation shown
 <td> Yamauchi &amp; Fujisawa (79b)
<tr>
 <td rowspan="2"> bov chromaffin extracts
 <td> 0.2 mM
 <td>
 <td> see 8-Br-cAMP in vitro
 <td> Haycock et al (85)
<tr>
 <td>
 <td> course
 <td>
 <td> MgATP-dependent phosphorylation;
    shown not to effect phosphatases dephosphorylating TH
  (NaF inhibits/MgCl<sub>2</sub> accelerates dephosphorylation);
  TFP completely inhibits Ca-mediated TH activation;
  DAG could stimulate gel-filtered TH requiring less Ca;
  TH activation also studied.
 <td> George et al (89)
<tr>
 <td> pure rat brainstem
 <td>
 <td>
 <td> activity vs pH narrow with Ca;
      additive with cAMP
 <td> Yamauch &amp; Fuj (80a)
<tr>
 <td> rat adrenal
 <td>
 <td>
 <td> TH unaffected by calcium
 <td> Yamauch &amp; Fuj (80a)
<tr>
 <td> Mg<sup>2+</sup>
 <td> bov adr med ext.
 <td> 1 mM
 <td>
 <td> same result as with Ca<sup>2+</sup>
 <td> Morita et al (77)
<tr>
 <td rowspan="3"> CaM (+Ca)
 <td> rat brainstem
 <td>
 <td> course
 <td> CaM kinase implicated;
      Km for cofactor reduced
 <td> Yamauch &amp; Fuj (80a)
<tr>
 <td> chromaffin cell secretory vesicles
 <td> 20&nbsp;&micro;g/ml + 0.1 mM Ca
 <td>
 <td> TH phosphorylation
 <td> Treiman et al (83)
<tr>
 <td> chromaffin extract
 <td>
 <td>
 <td> (see calcium section also)
     Addition of CaM or PtdSer does not enhance TH phosphoryaltion unless TH
  previously gel-filtered;
 <td> George et al (89)
<tr>
 <td> Seph G-25 filtration
 <td> rat striatum
 <td>
 <td>
 <td> Cofactor K<sub>m</sub> reduced:  also shown for hypothalamus
  and rat adr med.:  dopamine removed
 <td> Ames et al (78)
<tr>
 <td rowspan="3"> dopamine
 <td>  rat striata, hypothal, adr medulla
 <td>
 <td>
 <td> K<sub>i</sub> shown to increase 3-fold with phosphorylation;
  addition at physio conc. increases cofact. K<sub>m</sub> by 2-fold
 <td> Ames et al (78)
<tr>
 <td> rat striatal
 <td> 1&nbsp;&micro;M
 <td>
 <td> interesting analysis about pH optima,
     phosphorylation, and dopamine effects
 <td> Okuno &amp; Fujisawa (85)
<tr>
 <td> rat adr med
 <td> 1.0 mM
 <td>
 <td> TH activity decreased (higher conc. even greater depression)
 <td> Burke &amp; Joh (88)
<tr>
 <td rowspan="2"> DOPA
 <td> rat brain preoptic region
 <td> course
 <td>
 <td> IC<sub>50</sub> of DOPA=125&nbsp;&micro;M
      IC<sub>50</sub> of 2-hydroxyestradiol=50&nbsp;&micro;M
 <td> Lloyd &amp; Ebersole (80)
<tr>
 <td> rat adr med
 <td> 1.0 mM
 <td> 20 h
 <td> TH activity decreased by more than half
 <td> Burke &amp; Joh (88)
<tr>
 <td> catechol estrogens
 <td> bov caudate TH
 <td> 20&nbsp;&micro;M (IC<sub>50</sub>)
 <td>
 <td> competes with cofactor
 <td> Lloyd &amp; Weisz (78)
<tr>
 <td> rat brain preoptic region
 <td> course
 <td>
 <td> see DOPA Lloyd &amp; Ebersole (80)
 <td>
<tr>
 <td> PtdInos
 <td> purified rabbit adr med TH
 <td>
 <td>
 <td> TH activated: reduced cofactor K<sub>m</sub>;
   also inactivates by lowering Vmax
 <td> Lloyd (79)
<tr>
 <td rowspan="8"> PK-A
 <td> part pure rat caudate TH
 <td>
 <td>
 <td> TH activated (Vmax change, no Km cofactor change)
 <td> Joh et al (78)
<tr>
 <td rowspan="2"> part pure bov adr med TH
 <td>
 <td>
 <td> Commercial PK-A; phosphorylation and act.
 <td> Yamauchi &amp; Fuj (79a)
<tr>
 <td> 30&nbsp;&micro;g/ml comm. PKA
 <td> 20 m. at 30°
 <td> pH optimum shifts with phosphorylation;  charge of TH in
     regions postulated
 <td> Vigny &amp; Henry (82)
<tr>
 <td rowspan="3"> rat pheo TH pur.
 <td>
 <td>
 <td> cofactor Km reduced; PK-A indication the phosphorylated TH is more unstable
 <td> Vulliet et al (80)
<tr>
 <td>
 <td>
 <td> see Ca/CaM kinase
 <td> Vulliet et al (84)
<tr>
 <td>
 <td>
 <td> see PK-C
 <td> Vulliet et al (85)
<tr>
 <td>
 <td>
 <td>
 <td> used to compare peptide maps with PK-C phosphorylation
 <td> Albert et al (84)
<tr>
 <td> pure PC12
 <td>
 <td>
 <td> HPLC analysis of tryptic peptides of 3 kinases:  PK-A one peak at 60', 
 PK-C the 60' peak plus minor at 39', 43', 45-6', 58-9'. CaM-MPK II major at 
 39', minor at 60'. Edman done. Combination kinase additions done. PK-C does not 
 add to CaMMPK. PK-A adds to PK-C.  TH activation found only with PK-A
 <td>  Funakoshi et al (91)
<tr> <td>  PK-A cat subunit
 <td>
  rat pheo TH pur.
 <td>
 <td>
 <td>  see PK-A Vulliet et al (80)
 <td>  Vulliet et al (80)
<tr>
 <td>
 <td>
 <td>
 <td>
 <td>  thermolability studies
 <td>  Lazar et al (81)
<tr>
 <td> rat pheo TH
 <td>
 <td>
 <td>  HPLC analysis of PK-A, CaM MPK, and contaminating kinase;  Edman 
 sequencing identifies; 4 phosphorylation sites identified
 <td>  Campbell et al (86)
<tr>
 <td>  pure rat pheo TH
 <td>
 <td>
 <td>  TH activated; HPLC peptide analysis shows same as for in situ cAMP analogues (qv)
 <td>  Tachikawa et al (86)
<tr>
 <td> pure rat striatal TH
 <td>
 <td>
 <td>
  see the results under Ca/CaM kinase
 <td>
  Atkinson et al (87)
<tr>
 <td>
  pure PC12 TH
 <td>
 <td>
 <td>
  2D tryptic maps:
  single site for PK-A (peptide E);
  PK-C shows two spote (E and B);
  CaM kinase shows 5 peptides (incl. E and B, B strongly);
  depolarization increase in all peptides, but particularly B,D,E.
  TPA or OAG mimics PK-C pattern
 <td>
  Griffith &amp; Schulman (88)
<tr>
 <td>
 <td>
 <td>
 <td>
  HPLC tryptic peptide pattern shown A1 and A2 for PK-A;
  CaM MPK shows both A1,A2, but also C1 and C2.
  PDPK produces E peptide;
  PDPK also phosphorylates H25 peptide, shown to be Ser-31
 <td>
  Mitchell et al (89)
<tr>
 <td> chromaffin extract
 <td>
 <td>
 <td>  see cAMP section;
  PK-A stimulates phosphorylation
 <td>  George et al (89)
<tr> <td rowspan="10"> rat brain Ca/CaM kinase
 <td rowspan="2"> rat brain TH?
 <td>
 <td>
 <td> 70 kDa activator required for activation; activation shown
 <td> Yamauchi &amp; Fuj (81a)
<tr>
 <td>
 <td>
 <td> TH phosphorylation by kinase; must precede activator addition
 <td> Yamauchi &amp; Fuj (81b)
<tr>
 <td rowspan="2"> pheo source
 <td>
 <td>
 <td> relative phosphorylation incorporation among different enzymes;
      TH activation compared; major peptides studied on HPLC;
      Ca/CaM kinase shown in PC12 cells
 <td> Vulliet et al (84)
<tr>
 <td>
 <td>
 <td> see PK-C (peptides analyzed)
 <td> Vulliet et al (85)
<tr>
 <td>
 <td>
 <td>
 <td> show the presence of a PC12 Ca/CaM-dependent kinase
    (MAP-2 substrate Cleveland map similar to brain enzyme)
 <td> Nose et al (85)
<tr>
 <td>
 <td>
 <td>
 <td> see PK-A section; tryptic peptides analyzed on HPLC
 <td> Mitchell et al (89)
<tr>
 <td> pure PC12 TH
 <td>
 <td>
 <td> see PK-A section
 <td> Griffith &amp; Schulman (88)
<tr>
 <td>
 <td>
 <td>
 <td> phosphorylation but no activation;  HPLC of tryptic peptides
  same as pattern of in situ KCl or A23187 (qv)
 <td> Tachikawa et al (86)
<tr>
 <td> pure rat striatal TH
 <td>
 <td>
 <td> rabbit liver CaM kinase used also (CaM from bov brain).
  Additive phosphorylation with PK-A;
  HPLC analysis of tryptic peps: 16 min maj,
  28 min minor;  PK-A shows 28 min
  peptide is major.  No effect by CaM
  kinase on activity unless Yamauchi activator used;
  PK-A has major effect on cofactor Km, minor on Vmax
 <td> Atkinson et al (87)
<tr>
 <td> pure PC12
 <td>
 <td>
 <td> see PK-A section
 <td> Funakoshi et al (91)
<tr>
 <td rowspan="4"> PK-C
 <td>
 <td>
 <td>
 <td> 0.5 mol P/mol stoichio;  PK-C is quickly inactivated;
     activity correlated with phosphorylation;
  cofactor Km drops, (but Vmax increase also seen:
  could be due to subsatur cofactor); phosphorylaiton means
  dopamine Ki increases; 2D maps compare identically with PK-A treatment
 <td> Albert et al (84)
<tr>
 <td> pheo source
 <td>
 <td>
 <td> 0.7 mol P/mol; HPLC sep of trypt peptides:
     results similar to Albert et al showing PK-A;
    Edman “3rd cycle” of peptide A (PK-A and -C) and
   C (Ca/CaM kinase) labeled
 <td> Vulliet et al (85)
<tr>
 <td rowspan="2"> pure PC12 TH
 <td>
 <td>
 <td> see PK-A section
 <td> Griffith &amp; Schulman (88)
<tr>
 <td>
 <td>
 <td>
 <td> see PK-A section
 <td> Funakoshi et al (91)
<tr>
 <td>PK-G
 <td>
 <td>
 <td>
 <td>
  Compared to PK-A: activation and phosphorylation slower by
  PK-G than for PK-A;  cofactor Km reduced apparently
 <td> Roskoski et al (87)
<tr>
 <td> CK I &amp; II
 <td>
 <td>
 <td>
 <td> see Ca/CaM kinase
 <td> Vulliet et al (84)
<tr>
 <td> GSK-3 &amp; -4
 <td>
 <td>
 <td>
 <td> see Ca/CaM kinase
 <td> Vulliet et al (84)
<tr>
 <td> spermine
 <td> bov adr TH
 <td> 50&nbsp;&micro;M
 <td> course
 <td>
  polyamines previously shown to inhibit unphosphorylated TH.
  But spermine without effect on PK-A-treated TH on time course;
  Inhibition comp with cofactor, noncomp with tyrosine, some Vmax decrease
 <td> Kiuchi et al (87)
<tr>
 <td> ph'tase
 <td> pure bov adr TH
 <td>
 <td>
 <td> pure bov TH; tryptic peptides analyzed on TLE and HPLC;
   1st Edman sequence of bov  TH showing Ser-40 and Ser-19 also phosphorylated by these kinases in vitro;
  combination of inhibitor studies shown that P'tase 2A is chief dephosphorylator
  of TH.
 <td> Haavik et al (89)
<tr>
 <td> NGF
 <td> rat SCG
 <td>
 <td>
 <td> TH induction (??)
 <td> Max et al (78)
<tr>
 <td> tubulin
 <td>
 <td>
 <td>
 <td>  TH may bind to polymerized
  tubulin;  proteolyzed TH does not bind
 <td> Vigny et al (80)
<tr>
 <td rowspan="2"> trypsin
 <td>
 <td>
 <td> TH does not bind to polyanions
 <td> Vigny &amp; Henry (81)
<tr>
 <td> pure rat pheo TH
 <td>
 <td> course
 <td> progression of high MW bands of TH followed on gels; TH activation shown; which species has
  phosphate, loses phosphate?
 <td> Bonnefoy et al (88)
</table>
</body>
</html>
